| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50025 |
IM-9 |
human |
blood |
IgG-secreting B-lymphoblastic cell line. |
|
| 2 | general cells |
IFO50151 |
MEG-01 |
human |
bone marrow |
Contains Ph1 chromosome. Expresses megakaryoblastic markers as GPIIb/IIIa, GPIb, FVIII-related antigens, and also CD9, CDw14. It is reported that MEG-01 cells produced platelet-like particles. Morphological changes by phorbol ester. |
|
| 3 | general cells |
IFO50152 |
TuD-1-3 |
rat |
thymus |
This cell line is a clone of TuD-1 cells (IFO 50103). |
|
| 4 | general cells |
IFO50153 |
A549 |
human |
lung |
adenocarcinoma |
|
| 5 | general cells |
IFO50299 |
Balb/c 3T3 A31-1-13 |
mouse |
embryo, whole |
fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
| 6 | general cells |
JCRB0132.3 |
AH601.P3(JTC27) |
rat |
acites |
AH-601 cell line adupted to a serum free medium with long passage history. |
|
| 7 | general cells |
JCRB0153.2 |
tsJT16 |
rat |
embryo |
Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase. |
|
| 8 | general cells |
JCRB0703 |
FM3A APRT~ |
mouse |
mammary gland |
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse) |
|
| 9 | general cells |
JCRB1041 |
SEKI |
human |
skin of lower leg |
Human malignant melanoma cell line. |
|
| 10 | general cells |
JCRB1151 |
UE6E7T-12 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 11 | general cells |
JCRB1222.08 |
HGH1.11.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 12 | general cells |
JCRB1228 |
NCC-StC-K140 |
human |
Stomach |
Human stomach carcinoma cell line. |
|
| 13 | general cells |
JCRB1316.3 |
OHP138.H8.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 14 | general cells |
JCRB1337 |
DL-40 |
human |
peripheral blood |
Ki-1-positive T-cell lymphoma cell line. |
|
| 15 | general cells |
JCRB1340 |
RS-2 |
human |
perianal mass |
metastatic primitive neuroectodermal tumor cell line (derived from metastatic tumor). |
|
| 16 | general cells |
JCRB1342.06 |
MOR115.1.13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 17 | general cells |
JCRB1395 |
Kasumi-2 |
human |
blood |
B cell precursor leukemia [Cultivation is considerably difficult] |
|
| 18 | general cells |
JCRB1777 |
KKK-D131 |
human |
intrahepatic bile duct |
Human well differentiated tubular adenocarcinoma cell line established from biliary tract. |
|
| 19 | general cells |
JCRB2205 |
A9(Neo5) |
human chromosome-introduced |
skin |
contains human chromosome # 5 (MTA with Tottori Univ. is required.) |
|
| 20 | general cells |
JCRB4003 |
KE-43 |
human |
primary colonic carcinoma |
moderately differentiated adenocarcinoma established from primary tumor. Transition to poorly differentiated adenocarcinoma by passage.
|
|
| 21 | general cells |
JCRB9005 |
BALB/3T3 clone A31 |
mouse |
embryo |
fibroblast, contact inhibited, (BALB/c mouse) |
|
| 22 | general cells |
JCRB9092 |
7D4 |
mouse x rat |
hybridoma |
anti-murine IL-2 receptors (rat antibody) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.